Chairman and CEO @ Accolade Pharmaceuticals LLC (August 2013 - Present)
President and CMO @ (June 2024 - September 2025)
Chief Medical Officer @ (August 2018 - March 2023)
Executive Vice President, R and D and Director @ (February 2011 - March 2019)
CEO and Director @ Aqumen, Inc. (March 2005 - May 2011)
Mitchell Glass Education
The University of Chicago Pritzker School of Medicine 1973-1977
University of Chicago
AB 73 MD77 (Biology, Medicine)
1969-1977
Mitchell Glass Summary
Mitchell Glass, based in Wilmington, DE, US, is currently a Head of teams that developed 6 approved drugs and devices at CHRONIC AIRWAY THERAPEUTICS, Broom Street Associates. Mitchell Glass brings experience from previous roles at TNF Pharma (NASD TNFA), Chronic Airway Therapeutics, Broom Street Associates and Accolade Pharmaceuticals LLC. Mitchell Glass holds a 1973 - 1977 The University of Chicago Pritzker School of Medicine. Mitchell Glass has 2 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Mitchell Glass?
Find contact details for 700 million professionals.